AI assistant
Sending…
EXOZYMES INC. — Director's Dealing 2024
Nov 19, 2024
34055_dirs_2024-11-18_ca034042-db1e-4e45-a7b0-d7c5c063f9a8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Invizyne Technologies Inc (IZTC)
CIK: 0002010788
Period of Report: 2024-11-08
Reporting Person: Bowie James Ulrich (Director)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 577910 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Options for Common Stock | $2.44 | 2028-01-31 | Common Stock (25970) | Direct |
Footnotes
F1: The option vests as follows: The options vest as follows: The shares vest at a rate of 433 shares per month. All shares will have vested by 01/31/2026 become exercisable once vested.
More from EXOZYMES INC.
Regulatory Filings
2026
May 29
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 7
Regulatory Filings
2026
Apr 10
Regulatory Filings
2026
Apr 9
Regulatory Filings
2026
Mar 31
Regulatory Filings
2026
Feb 5
Regulatory Filings
2026
Jan 26
Regulatory Filings
2026
Jan 26
Regulatory Filings
2026
Jan 16